With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy offers low-dose naltrexone, ketamine, and other alternative treatment options for the growing mental health crisis in the United States.

FORT MYERS, Fla. — Noah Song’s dream of pitching in the major leagues has never been closer. The 2019 Naval Academy product had a chance to skip the minor leagues altogether when the Philadelphia ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Westford, USA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Compounding pharmacies are becoming increasingly popular as patients demand more customizable and detailed medications. These pharmacies offer a wider ...

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...

The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite the recommendation of its own advisory committee against approval — came as a surprise to many. But to me, that ...

If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy is featured in Inc. 5000 this month discussing low-dose Naltrexone, Ketamine, and other treatment options as alternative medicine during ...

Pharmaceutical companies in Europe are blocking the sale of drugs used for lethal injection in the U.S. That has states that use the drugs turning to compounding pharmacies to create them. David ...

ORLANDO, FL--(Marketwired - Feb 17, 2015) - QmedRx, a compounding pharmacy servicing patients in all 50 states through in-home delivery, has concerns about the new US Food and Drug Administration (FDA ...

By Mariam Sunny March 3 (Reuters) - Strive Pharmacy said on Tuesday it has no plans to resume sales of a compounded version of Novo Nordisk's oral semaglutide, pushing back on an earlier media report ...